| Indicators | Browse All

Aditxt, Inc. (ADTX)

Healthcare | Biotechnology | Mountain View, United States | OTC Markets OTCPK
0.01 USD

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 3:48 a.m. EDT

The investment case for this biotechnology firm has collapsed entirely. Fundamentally, the company is bleeding cash with massive operating losses, negative free cash flow, and a balance sheet where debt far exceeds cash reserves. The market has already priced in a complete failure, evidenced by a five-year price trajectory that has erased 100% of shareholder value, with every single year showing a double-digit percentage decline. Recent headlines confirm the gravity of the situation, detailing a record 22-day selloff, a desperate 1-for-27 reverse split to prop up the share count, and the issuance of more secured notes to stave off liquidity crises. With no dividend history and a forward P/E that is mathematically undefined due to negative earnings, there is no margin of safety and no path to recovery visible in the data. The short-term outlook remains perilous given the ongoing capital raising efforts and the low-confidence statistical forecast predicting further downside, while the long-term outlook is non-existent for a business that has lost all its equity value over the last half-decade.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.842018
AutoARIMA0.933210
AutoETS1.000095
MSTL1.862904

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 31%
H-stat 1.00
Ljung-Box p 0.000
Jarque-Bera p 0.637
Excess Kurtosis -0.69
Attribute Value
Sector Healthcare
Revenue per Share 0.371
Market Cap 5,987,859
Forward P/E 0.00
Previous Name ADiTx Therapeutics, Inc.
Website https://www.aditxt.com

Info Dump

Attribute Value
52 Week Change -0.99999976
Address1 2,569 Wyandotte Street
Address2 Suite 101
All Time High 4,676,572,900,000.0
All Time Low 0.002
Ask 0.0057
Ask Size 944,000
Average Daily Volume10 Day 45,017,130
Average Daily Volume3 Month 418,684,350
Average Volume 418,684,350
Average Volume10Days 45,017,130
Bid 0.0054
Bid Size 700,000
Book Value -861.428
City Mountain View
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.006
Current Ratio 0.064
Custom Price Alert Confidence LOW
Date Short Interest 1,781,481,600
Day High 0.0059
Day Low 0.0048
Display Name Aditxt
Earnings Timestamp End 1,755,892,800
Earnings Timestamp Start 1,755,547,200
Ebitda -18,075,768
Ebitda Margins 0.0
Enterprise To Ebitda -0.115
Enterprise To Revenue 144.539
Enterprise Value 2,072,114
Eps Forward -11.29
Eps Trailing Twelve Months -1,380.8
Esg Populated 0
Exchange PNK
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.00484
Fifty Day Average Change 0.00116
Fifty Day Average Change Percent 0.23966941
Fifty Two Week Change Percent -99.99998
Fifty Two Week High 27,092.88
Fifty Two Week High Change -27,092.875
Fifty Two Week High Change Percent -0.99999976
Fifty Two Week Low 0.002
Fifty Two Week Low Change 0.0039999997
Fifty Two Week Low Change Percent 1.9999998
Fifty Two Week Range 0.002 - 27092.88
Financial Currency USD
First Trade Date Milliseconds 1,593,523,800,000
Float Shares 181,608
Forward Eps -11.29
Forward P E -0.00053144374
Free Cashflow -12,346,033
Full Exchange Name OTC Markets OTCPK
Full Time Employees 26
Fullday Price 0.006
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.19894
Gross Profits 2,852
Has Pre Post Market Data 0
Held Percent Insiders 0.00064000004
Held Percent Institutions 0.00051
Implied Shares Outstanding 997,976,542
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,779,062,400
Last Split Factor 1:27
Long Business Summary Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It develops ADI-100 for skin grafting, psoriasis, and type-1 diabetes. In addition, the company provides Pearsanta that develops molecular tests based on the mitochondrial DNA (mtDNA) to develop tests for early detection of cancer; Mitomic targets mutations in mitochondrial DNA (mtDNA) to detect disease; Mitomic prostate test a blood-based assay that quantifies the level of the 3.4kb mtDNA deletion; and Mitomic endometriosis test, a blood-based assay that quantifies the level of one or more mtDNA deletions. Further, it offers Adivir for commercial development of products to address significant unmet needs in infectious disease and population health; and Adifem address critical unmet needs in women health. The company has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
Long Name Aditxt, Inc.
Market us_market
Market Cap 5,987,859
Market State PREPRE
Max Age 86,400
Message Board Id finmb_551021594
Most Recent Quarter 1,774,915,200
Name Change Date 2,026-08-28
Net Income To Common -53,338,868
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 5,508,830
Open 0.0056
Operating Cashflow -18,553,676
Operating Margins -358.73535
Payout Ratio 0.0
Phone 650 870 1200
Prev Name ADiTx Therapeutics, Inc.
Previous Close 0.006
Price Hint 4
Price To Book -0.000006965179
Price To Sales Trailing12 Months 417.6799
Profit Margins 0.0
Quick Ratio 0.021
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 0.0059
Regular Market Day Low 0.0048
Regular Market Day Range 0.0048 - 0.0059
Regular Market Open 0.0056
Regular Market Previous Close 0.006
Regular Market Price 0.006
Regular Market Time 1,787,860,800
Regular Market Volume 15,687,576
Return On Assets -0.50756
Revenue Growth 10.944
Revenue Per Share 0.371
Sand P52 Week Change 0.1890428
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 997,976,542
Shares Percent Shares Out 0.345
Shares Short 281,498
Shares Short Previous Month Date 1,778,803,200
Shares Short Prior Month 3,386
Short Name Aditxt, Inc.
Short Percent Of Float 0.345
Short Ratio 0.0
Source Interval 15
State CA
Symbol ADTX
Total Cash 268,852
Total Cash Per Share 0.33
Total Debt 4,233,669
Total Revenue 14,336
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1,380.8
Trailing Peg Ratio None
Triggerable 0
Two Hundred Day Average 149.05693
Two Hundred Day Average Change -149.05093
Two Hundred Day Average Change Percent -0.99995977
Type Disp Equity
Volume 15,687,576
Website https://www.aditxt.com
Zip 94,043